Company Overview - Novartis (NVS) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, NVS shares increased by 1.92%, while the Zacks Large Cap Pharmaceuticals industry rose by 2.63% [5] - In a longer time frame, NVS shares have shown a monthly price change of 7.97%, outperforming the industry's 6.66% [5] - Over the past quarter, NVS shares have risen by 7.56%, and over the last year, they are up 17.5%, compared to the S&P 500's -5.55% and 13.72% respectively [6] Trading Volume - NVS has an average 20-day trading volume of 2,345,418 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Estimates - In the past two months, 5 earnings estimates for NVS have been revised upwards, while only 1 has been revised downwards, leading to an increase in the consensus estimate from $8.45 to $8.69 [9] - For the next fiscal year, 4 estimates have moved upwards and 1 has been revised downwards [9] Conclusion - Given the strong momentum indicators and positive earnings outlook, NVS is recommended as a stock to consider for near-term investment opportunities [11]
Novartis (NVS) is a Great Momentum Stock: Should You Buy?